Myricetin ameliorates atherosclerosis in the low-density-lipoprotein receptor knockout mice by suppression of cholesterol accumulation in macrophage foam cells
Abstract Background Myricetin, a major flavonoid found in several foods including berries, grapes and wine, exhibited strong antioxidant potency, yet the effect on atherosclerosis is not fully understood. In this study, we examined the effect of myricetin on lipid accumulation in macrophage and athe...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-04-01
|
Series: | Nutrition & Metabolism |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12986-019-0354-7 |
_version_ | 1818148435092570112 |
---|---|
author | Zhe Meng Mengyu Wang Junhui Xing Yuzhou Liu Haiyu Li |
author_facet | Zhe Meng Mengyu Wang Junhui Xing Yuzhou Liu Haiyu Li |
author_sort | Zhe Meng |
collection | DOAJ |
description | Abstract Background Myricetin, a major flavonoid found in several foods including berries, grapes and wine, exhibited strong antioxidant potency, yet the effect on atherosclerosis is not fully understood. In this study, we examined the effect of myricetin on lipid accumulation in macrophage and atherosclerosis in atherosclerosis-prone low density lipoprotein receptor-deficient (Ldlr −/− ) mice. Methods Ldlr −/− mice were fed an atherogenic diet supplemented with myricetin (0.15% in the diet, v/v) for 8 weeks. Body weight, adipose tissue weight, food intake, serum biochemical parameters were measured. Atherosclerosis lesions and macrophages accumulaton in lesions were analyzed and quantified. Macrophages were exposed to 20 μM of myricetin before incubated with oxidized low-density lipoprotein (ox-LDL) (25μg/mL) or Dil-ox-LDL for the indicated time. Lipid uptake and foam cell formation were evaluated by flow cytometry and microscopy. The intracellular lipids were extracted and measured. mRNA expression and protein of cholesterol metabolism related receptors were analyzed. Results Myricetin administration reduced the weight, plasma lipid levels but not food intake in Ldlr −/− mice when fed an atherogenic diet. Myceritin-treated Ldlr −/− mice displayed significantly less atherosclerotic areas and macrophages in the cross sections of the aortic root. There were also less lipophilic areas in En face Oil red O staining of aorta from myceritin-treated Ldlr −/− mice. Myceritin treatment also markedly ameliorated ox-LDL-induced cholesterol accumulation in macrophages. The expression of CD36 were decreased in myricetin treated macrophages with ox-LDL incubation, while scavenger receptors class A (SR-A) and scavenger receptors class B (SR-BI) expression was not altered, indicating that these effect of myricetin were dependent on CD36 pathway. Conclusions Our findings indicated that myricetin suppressed cholesterol accumulation in macrophage foam cells by inhibition of CD36-mediated ox-LDL uptake, and suggested myricetin may have an important therapeutic function for atherosclerosis. |
first_indexed | 2024-12-11T12:51:05Z |
format | Article |
id | doaj.art-3ef46ca6fb094a1b939446c890d40619 |
institution | Directory Open Access Journal |
issn | 1743-7075 |
language | English |
last_indexed | 2024-12-11T12:51:05Z |
publishDate | 2019-04-01 |
publisher | BMC |
record_format | Article |
series | Nutrition & Metabolism |
spelling | doaj.art-3ef46ca6fb094a1b939446c890d406192022-12-22T01:06:41ZengBMCNutrition & Metabolism1743-70752019-04-011611910.1186/s12986-019-0354-7Myricetin ameliorates atherosclerosis in the low-density-lipoprotein receptor knockout mice by suppression of cholesterol accumulation in macrophage foam cellsZhe Meng0Mengyu Wang1Junhui Xing2Yuzhou Liu3Haiyu Li4Department of Cardiology, The First Affiliated Hospital of Zhengzhou UniversityDepartment of Cardiology, The First Affiliated Hospital of Zhengzhou UniversityDepartment of Cardiology, The First Affiliated Hospital of Zhengzhou UniversityDepartment of Cardiology, The First Affiliated Hospital of Zhengzhou UniversityDepartment of Cardiology, The First Affiliated Hospital of Zhengzhou UniversityAbstract Background Myricetin, a major flavonoid found in several foods including berries, grapes and wine, exhibited strong antioxidant potency, yet the effect on atherosclerosis is not fully understood. In this study, we examined the effect of myricetin on lipid accumulation in macrophage and atherosclerosis in atherosclerosis-prone low density lipoprotein receptor-deficient (Ldlr −/− ) mice. Methods Ldlr −/− mice were fed an atherogenic diet supplemented with myricetin (0.15% in the diet, v/v) for 8 weeks. Body weight, adipose tissue weight, food intake, serum biochemical parameters were measured. Atherosclerosis lesions and macrophages accumulaton in lesions were analyzed and quantified. Macrophages were exposed to 20 μM of myricetin before incubated with oxidized low-density lipoprotein (ox-LDL) (25μg/mL) or Dil-ox-LDL for the indicated time. Lipid uptake and foam cell formation were evaluated by flow cytometry and microscopy. The intracellular lipids were extracted and measured. mRNA expression and protein of cholesterol metabolism related receptors were analyzed. Results Myricetin administration reduced the weight, plasma lipid levels but not food intake in Ldlr −/− mice when fed an atherogenic diet. Myceritin-treated Ldlr −/− mice displayed significantly less atherosclerotic areas and macrophages in the cross sections of the aortic root. There were also less lipophilic areas in En face Oil red O staining of aorta from myceritin-treated Ldlr −/− mice. Myceritin treatment also markedly ameliorated ox-LDL-induced cholesterol accumulation in macrophages. The expression of CD36 were decreased in myricetin treated macrophages with ox-LDL incubation, while scavenger receptors class A (SR-A) and scavenger receptors class B (SR-BI) expression was not altered, indicating that these effect of myricetin were dependent on CD36 pathway. Conclusions Our findings indicated that myricetin suppressed cholesterol accumulation in macrophage foam cells by inhibition of CD36-mediated ox-LDL uptake, and suggested myricetin may have an important therapeutic function for atherosclerosis.http://link.springer.com/article/10.1186/s12986-019-0354-7MyricetinMacrophageAtherosclerosisCD36 |
spellingShingle | Zhe Meng Mengyu Wang Junhui Xing Yuzhou Liu Haiyu Li Myricetin ameliorates atherosclerosis in the low-density-lipoprotein receptor knockout mice by suppression of cholesterol accumulation in macrophage foam cells Nutrition & Metabolism Myricetin Macrophage Atherosclerosis CD36 |
title | Myricetin ameliorates atherosclerosis in the low-density-lipoprotein receptor knockout mice by suppression of cholesterol accumulation in macrophage foam cells |
title_full | Myricetin ameliorates atherosclerosis in the low-density-lipoprotein receptor knockout mice by suppression of cholesterol accumulation in macrophage foam cells |
title_fullStr | Myricetin ameliorates atherosclerosis in the low-density-lipoprotein receptor knockout mice by suppression of cholesterol accumulation in macrophage foam cells |
title_full_unstemmed | Myricetin ameliorates atherosclerosis in the low-density-lipoprotein receptor knockout mice by suppression of cholesterol accumulation in macrophage foam cells |
title_short | Myricetin ameliorates atherosclerosis in the low-density-lipoprotein receptor knockout mice by suppression of cholesterol accumulation in macrophage foam cells |
title_sort | myricetin ameliorates atherosclerosis in the low density lipoprotein receptor knockout mice by suppression of cholesterol accumulation in macrophage foam cells |
topic | Myricetin Macrophage Atherosclerosis CD36 |
url | http://link.springer.com/article/10.1186/s12986-019-0354-7 |
work_keys_str_mv | AT zhemeng myricetinamelioratesatherosclerosisinthelowdensitylipoproteinreceptorknockoutmicebysuppressionofcholesterolaccumulationinmacrophagefoamcells AT mengyuwang myricetinamelioratesatherosclerosisinthelowdensitylipoproteinreceptorknockoutmicebysuppressionofcholesterolaccumulationinmacrophagefoamcells AT junhuixing myricetinamelioratesatherosclerosisinthelowdensitylipoproteinreceptorknockoutmicebysuppressionofcholesterolaccumulationinmacrophagefoamcells AT yuzhouliu myricetinamelioratesatherosclerosisinthelowdensitylipoproteinreceptorknockoutmicebysuppressionofcholesterolaccumulationinmacrophagefoamcells AT haiyuli myricetinamelioratesatherosclerosisinthelowdensitylipoproteinreceptorknockoutmicebysuppressionofcholesterolaccumulationinmacrophagefoamcells |